Trial Profile
Denosumab in Current Users of Bisphosphonates for Glucocorticoid-induced Osteoporosis: a Randomized Controlled Trial.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Bisphosphonates
- Indications Corticosteroid-induced osteoporosis
- Focus Therapeutic Use
- 29 Oct 2012 Investigational drug identified as Bisphosphonates as reported by ClinicalTrials.gov.
- 29 Oct 2012 Planned End Date changed from 1 Feb 2014 to 1 Apr 2014 as reported by ClinicalTrials.gov.
- 15 Apr 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.